[1] |
哈丽达·夏尔甫哈孜, 冯娟, 范晓棠, 等. 进展期胃癌根治术后5年预后因素分析及生存预测模型的建立[J]. 胃肠病学和肝病学杂志, 2020, 29(10): 1129-1133.
|
[2] |
Strong VE, Wu AW, Selby LV, et al. Differences in gastric cancer survival between the U.S. and China[J]. J Surg Oncol, 2015, 112(1): 31-37.
|
[3] |
Duan S, Wang P, Liu F, et al. Novel immune-risk score of gastric cancer: A molecular prediction model combining the value of immune-risk status and chemosensitivity[J]. Cancer Med, 2019, 8(5): 2675-2685.
|
[4] |
Jiang Y, Zhang Q, Hu Y, et al. ImmunoScore signature: A prognostic and predictive tool in gastric cancer[J]. Ann Surg, 2018, 267(3): 504-513.
|
[5] |
Wu C, Wang N, Zhou H, et al. Development and validation of a nomogram to individually predict survival of young patients with nonmetastatic gastric cancer: A retrospective cohort study[J]. Saudi J Gastroenterol, 2019, 25(4): 236-244.
|
[6] |
Wang J, Qin D, Tao Z, et al. Identification of cuproptosis-related subtypes, construction of a prognosis model, and tumor microenvironment landscape in gastric cancer[J]. Front Immunol, 2022, 13: 1056932.
|
[7] |
Shao W, Yang Z, Fu Y, et al. The pyroptosis-related signature predicts prognosis and indicates immune microenvironment infiltration in gastric cancer[J]. Front Cell Dev Biol, 2021, 9: 676485.
|
[8] |
周新童, 党胜春. 基于不同数据库来源数据的胃癌长链非编码RNA预后预测模型构建[J]. 中国普通外科杂志, 2020, 29(10): 1187-1194.
|
[9] |
Cai C, Yang L, Zhuang X, et al. A five-lncRNA model predicting overall survival in gastric cancer compared with normal tissues[J]. Aging, 2021, 13(21): 24349-24359.
|
[10] |
Chen T, Zhang C, Liu Y, et al. A gastric cancer lncRNAs model for MSI and survival prediction based on support vector machine[J]. BMC Genomics, 2019, 20(1): 846.
|
[11] |
Zhu Y, Fang X, Wang L, et al. A predictive nomogram for early death of metastatic gastric cancer: A retrospective study in the SEER database and China[J]. J Cancer, 2020, 11(18): 5527-5535.
|
[12] |
Bando E, Ji X, Kattan MW, et al. Development and validation of a pretreatment nomogram to predict overall survival in gastric cancer[J]. Cancer Med, 2020, 9(16): 5708-5718.
|
[13] |
Hu X, Yang Z, Chen S, et al. Development and external validation of a prognostic nomogram for patients with gastric cancer after radical gastrectomy[J]. Ann Transl Med, 2021, 9(23): 1742.
|
[14] |
张原, 戎泽印, 黄陈. "偏近、朝远":基于原发部位胃癌发生机制研究进展及临床治疗决策思辨[J]. 中华普通外科杂志, 2021, 36(3): 230-234.
|
[15] |
Jeong SH, Kim RB, Park SY, et al. Nomogram for predicting gastric cancer recurrence using biomarker gene expression[J]. Eur J Surg Oncol, 2020, 46(1): 195-201.
|
[16] |
Bai Y, Wei C, Zhong Y, et al. Development and validation of a prognostic nomogram for gastric cancer based on DNA methylation-driven differentially expressed genes[J]. Int J Biol Sci, 2020, 16(7): 1153-1165.
|
[17] |
Deng J, Liang H, Ying G, et al. Methylation of ras association domain protein 10 (RASSF10) promoter negative association with the survival of gastric cancer[J]. Am J Cancer Res, 2014, 4(6): 916-923.
|
[18] |
Cao W, Zhou W, Li M, et al. A novel signature based on CeRNA and immune status predicts prognostic risk and drug sensitivity in gastric cancer patients[J]. Front Immunol, 2022, 13: 951135.
|
[19] |
Aerts HJ, Velazquez ER, Leijenaar RT, et al. Decoding tumour phenotype by noninvasive imaging using a quantitative radiomics approach[J]. Nat Commun, 2014, 5: 4006.
|
[20] |
Wang Y, Liu W, Yu Y, et al. CT radiomics nomogram for the preoperative prediction of lymph node metastasis in gastric cancer[J]. Eur Radiol, 2020, 30(2): 976-986.
|
[21] |
Jiang Y, Chen C, Xie J, et al. Radiomics signature of computed tomography imaging for prediction of survival and chemotherapeutic benefits in gastric cancer[J]. EBioMedicine, 2018, 36: 171-182.
|
[22] |
Yoshida H, Shimazu T, Kiyuna T, et al. Automated histological classification of whole-slide images of gastric biopsy specimens[J]. Gastric Cancer, 2018, 21(2): 249-257.
|
[23] |
Que SJ, Chen QY, Zhong Q, et al. Application of preoperative artificial neural network based on blood biomarkers and clinicopathological parameters for predicting long-term survival of patients with gastric cancer[J]. World J Gastroenterol, 2019, 25(43): 6451-6464.
|
[24] |
Nilsaz-Dezfouli H, Abu-Bakar MR, Arasan J, et al. Improving gastric cancer outcome prediction using single time-point artificial neural network models[J]. Cancer Inform, 2017, 16: 1176935116686062.
|
[25] |
Dong D, Fang MJ, Tang L, et al. Deep learning radiomic nomogram can predict the number of lymph node metastasis in locally advanced gastric cancer: An international multicenter study[J]. Ann Oncol, 2020, 31(7): 912-920.
|
[26] |
Jin C, Jiang Y, Yu H, et al. Deep learning analysis of the primary tumour and the prediction of lymph node metastases in gastric cancer[J]. Br J Surg, 2021, 108(5): 542-549.
|
[27] |
Jiang Y, Zhang Z, Yuan Q, et al. Predicting peritoneal recurrence and disease-free survival from CT images in gastric cancer with multitask deep learning: A retrospective study[J]. Lancet Digit Health, 2022, 4(5): e340-e350.
|
[28] |
Dai S, Liu T, Liu X Q, et al. Identification of an immune-related signature predicting survival risk and immune microenvironment in gastric cancer[J]. Front Cell Dev Biol, 2021, 9: 687473.
|
[29] |
Cui Y, Zhang J, Li Z, et al. A CT-based deep learning radiomics nomogram for predicting the response to neoadjuvant chemotherapy in patients with locally advanced gastric cancer: A multicenter cohort study[J]. EClinicalMedicine, 2022, 46: 101348.
|
[30] |
Dai S, Huang Y, Liu T, et al. Development and validation of RNA binding protein-applied prediction model for gastric cancer[J]. Aging (Albany NY), 2021, 13(4): 5539-5552.
|